BATM Advanced Communications Ltd. (BVCLF) Fair Value & Analysis
Healthcare · US · Market cap $340K
What is BATM Advanced Communications Ltd. really worth?
BATM Advanced Communications Ltd.
BVCLF · US
Below-average quality, and trading another 26% above our fair value of $0.0174.
Risks
Fair value as of: Aug 29, 2026
From 6 valuation models · updated 3 days ago
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case ($0.0175). The favourable scenario is already priced in.
- Solid but not exceptional quality (45/100) and above fair value, neither a clear bargain nor a standout compounder.
- The models converge in a tight band ($0.0174 to $0.0175), unusually little disagreement for a valuation.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 29, 2026.
How to read this chart
60‑month range $0.0006 – $1.29 · fair‑value band $0.0174 – $0.0175 · the $0.0220 price screens above the $0.0174 fair value. Dashed = 300-day average. As of Aug 29, 2026.
Analysis
BATM Advanced Communications Ltd. (BVCLF) currently trades at $0.0220, while our model-based Fair Value estimate is $0.0174, implying the stock looks roughly 26.4% overvalued today. The Quality Score stands at 45/100 (below-average quality), in the Healthcare sector. Bull case: the Multiples group reads highest at a median of $0.0174 per share, and 1 of the 6 models we run sit above the $0.0220 price. Bear case: the Earnings-Based group reads lowest at $0.0091, and 5 of the 6 models stay below the price. Evidence for this calculation is low.
Over the trailing twelve months, BATM Advanced Communications Ltd. generated revenue of $123M at a net margin of −14.9%. Revenue grew 7.5% year over year. It earns a return on equity of −16.2%. Fundamentals as of Aug 29, 2026
Our scenario range runs from $0.0174 (bear case) to $0.0175 (bull case); at $0.0220, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at −47% fair-value upside, at −21%, BVCLF screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 6 models by family
Widest divergence: Multiples ($0.0174) versus Earnings-Based ($0.0091). Highest evidence: EPV (71).
Notify me when BVCLF reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 29, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 43 · Market factors (momentum, volatility) 43
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
BATM Advanced Communications Ltd., together with its subsidiaries, engages in the development, production, and supply of real-time technologies and associated services in Israel, the United States, and Europe. It operates through four segments: Cyber, Networking, Diagnostics, and Non-core.
Full company description
BATM Advanced Communications Ltd., together with its subsidiaries, engages in the development, production, and supply of real-time technologies and associated services in Israel, the United States, and Europe. It operates through four segments: Cyber, Networking, Diagnostics, and Non-core. The Cyber segment provides integrated hardware and software solutions for network encryption, including hardware security modules. The Networking segment engages in researching and developing, and marketing of data communication products, including Edgility, an open edge software platform that enables the deployment and life-cycle management of apps, and compute devices at the edge of the network; and a range of carrier grade products for switching and routing hardware and software products. The Diagnostics segment is involved in the development, sale, and distribution of in vitro diagnostics reagents and instruments, including proprietary products that focus on molecular diagnostics by test type and infectious disease by application area. The Non-core segment distributes pharmaceutical and environmental monitoring products, as well as engages in the production of ecofriendly pathogenic waste treatment solutions for medical, agricultural, and pharmaceutical applications. The company provides software services, such as training and technical support; laboratory service and maintenance; and construction contract services. BATM Advanced Communications Ltd. was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
BATM Advanced Communications Ltd. reported revenue of $117M in FY2024 versus $184M in FY2020, a compound −10.6%/yr. Reported net income was −$22.3M in FY2024.
BVCLF screens 26% overvalued. Compare with Intuitive Surgical, Inc →
Peer Group
Medical Instruments & Supplies · 205 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 29, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $367.07 | $150.04 | −59% |
| EssilorLuxottica Société anonyme EL | €160.35 | €94.93 | −41% |
| Medline Inc MDLN | $34.58 | $30.15 | −13% |
| Becton, Dickinson and Company BDX | $190.21 | $100.46 | −47% |
| Alcon Inc ALC | $72.23 | $39.78 | −45% |
| ResMed Inc RMD | A$32.39 | A$26.05 | −20% |
| West Pharmaceutical Services, Inc WST | $337.47 | $141.58 | −58% |
| Sartorius Stedim Biotech S.A DIM | €197.70 | €48.88 | −75% |
| Straumann Holding STMN | CHF 92.18 | CHF 47.31 | −49% |
| Sartorius Aktiengesellschaft SRT3 | €253.50 | €63.30 | −75% |
Compare BATM Advanced Communications Ltd. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is BATM Advanced Communications Ltd. (BVCLF) overvalued or undervalued?
What is the fair value of BVCLF?
What is the quality score of BVCLF?
What is the revenue of BATM Advanced Communications Ltd. (BVCLF)?
What is the net profit margin of BVCLF?
Watch BATM Advanced Communications Ltd. in the live analysis
One click puts BATM Advanced Communications Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.